Skip to main content
SpringerLink
Log in

131I-Meta-iodobenzylguanidine in the Management of Metastatic Midgut Carcinoid Tumors

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

The management of metastatic neuroendocrine tumors incorporates multimodal therapy with surgery, biotherapy, and chemotherapy. Tumor-targeted therapies using radiolabeled octreotide and meta-iodobenzylguanidine (mIBG) represent a novel treatment approach. The aim of this study was to evaluate the effectiveness of 131I-mIBG in the treatment of metastatic midgut carcinoid tumors. survival outcomes were assessed for patients treated at two regional cancer centers and then compared. One center used 131I-mIBG routinely in the management of metastatic carcinoid tumors (center A), and the other did not use this modality (center B). Only patients with histologically proven metastatic carcinoid tumor shown, or thought most likely, to be of midgut origin were included in the study. During the period 1980 to 2002, a series of 58 patients from center A with metastatic carcinoid tumor arising from the midgut underwent multimodality therapy with the addition of 131I-mIBG. Their median age was 64 years. The median dose of 131I-mIBG administered was 6751 MBq, and there was an average of 2.8 treatments per patient. During the same period, 58 patients with metastatic carcinoid were treated at center B with similar multimodality therapy without the use of 131I-mIBG therapy. Their median age was 65 years. Survivals at 3 and 5 years were 77% and 63%, respectively (95% CI 47–75), for group A. The 3- and 5-year survivals for group B were 56% and 47% (95% CI 34–59), respectively. The mean follow-up was 6.6 years for group A and 5.0 years for group B. Although retrospective in nature, this study suggests that the addition of 131I-mIBG therapy to the treatment protocol of patients with metastatic midgut carcinoid tumors prolongs survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.
Fig. 3.

Similar content being viewed by others

References

  1. E Crocetti (1997) ArticleTitleGastrointestinal carcinoid tumours: a population-based study Ital. J. Gastroenterol. Hepatol. 29 135–137 Occurrence Handle1:STN:280:DyaK1czhtVWlsw%3D%3D Occurrence Handle9646193

    CAS  PubMed  Google Scholar 

  2. K Hemminki X Li (2001) ArticleTitleIncidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden Cancer 92 2204–2210 Occurrence Handle10.1002/1097-0142(20011015)92:8<2204::AID-CNCR1564>3.0.CO;2-R Occurrence Handle1:STN:280:DC%2BD3MrkvVKlsg%3D%3D Occurrence Handle11596039

    Article  CAS  PubMed  Google Scholar 

  3. IM Modlin KD Lye M Kidd (2003) ArticleTitleA 5-decade analysis of 13,715 carcinoid tumors Cancer 97 934–959 Occurrence Handle10.1002/cncr.11105 Occurrence Handle12569593

    Article  PubMed  Google Scholar 

  4. T Berge F Linell (1976) ArticleTitleCarcinoid tumours: frequency in a defined population during a 12-year period Acta Pathol. Microbiol. Scand. [A] 84 322–330 Occurrence Handle1:STN:280:CSmB2svltVQ%3D

    CAS  Google Scholar 

  5. IM Modlin A Sandor (1997) ArticleTitleAn analysis of 8305 cases of carcinoid tumors Cancer 79 813–829 Occurrence Handle10.1002/(SICI)1097-0142(19970215)79:4<813::AID-CNCR19>3.0.CO;2-2 Occurrence Handle1:STN:280:ByiC2sjhs1w%3D Occurrence Handle9024720

    Article  CAS  PubMed  Google Scholar 

  6. KO Shebani WW Souba DM Finkelstein et al. (1999) ArticleTitlePrognosis and survival in patients with gastrointestinal tract carcinoid tumors Ann. Surg. 229 815–821 Occurrence Handle10.1097/00000658-199906000-00008 Occurrence Handle1:STN:280:DyaK1M3ptVGlsQ%3D%3D Occurrence Handle10363895

    Article  CAS  PubMed  Google Scholar 

  7. JR Olney LF Urdaneta AS Jurf ParticleAl et al. (1985) ArticleTitleCarcinoid tumors of the gastrointestinal tract Am. Surg. 51 37–41 Occurrence Handle1:STN:280:BiqD1MrivVU%3D Occurrence Handle3966721

    CAS  PubMed  Google Scholar 

  8. S Saha S Hoda R Godfrey et al. (1989) ArticleTitleCarcinoid tumors of the gastrointestinal tract: a 44-year experience South. Med. J. 82 1501–1505 Occurrence Handle1:STN:280:By%2BD1cvmtlc%3D Occurrence Handle2595419

    CAS  PubMed  Google Scholar 

  9. D O’Toole M Ducreux G Bommelaer et al. (2000) ArticleTitleTreatment of carcinoid syndrome: a prospective crossover evaluation of lanreotide versus octreotide in terms of efficacy, patient acceptability, and tolerance Cancer 88 770–776 Occurrence Handle10.1002/(SICI)1097-0142(20000215)88:4<770::AID-CNCR6>3.0.CO;2-0 Occurrence Handle1:CAS:528:DC%2BD3cXhtlGntbo%3D Occurrence Handle10679645

    Article  CAS  PubMed  Google Scholar 

  10. M Rohaizak JR Farndon (2002) ArticleTitleUse of octreotide and lanreotide in the treatment of symptomatic non-resectable carcinoid tumours ANZ J. Surg. 72 635–638 Occurrence Handle10.1046/j.1445-2197.2002.02507.x Occurrence Handle12269913

    Article  PubMed  Google Scholar 

  11. P Cordelier JP Esteve C Bousquet et al. (1997) ArticleTitleCharacterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5 Proc. Natl. Acad. Sci. USA 94 9343–9348 Occurrence Handle10.1073/pnas.94.17.9343 Occurrence Handle1:CAS:528:DyaK2sXls1Klsbk%3D Occurrence Handle9256484

    Article  CAS  PubMed  Google Scholar 

  12. WL Leong JL Pasieka (2002) ArticleTitleRegression of metastatic carcinoid tumors with octreotide therapy: two case reports and a review of the literature J. Surg. Oncol. 79 180–187 Occurrence Handle10.1002/jso.10062.abs Occurrence Handle11870669

    Article  PubMed  Google Scholar 

  13. EM Tiensuu Janson H Ahlstrom T Andersson et al. (1992) ArticleTitleOctreotide and interferon alfa: a new combination for the treatment of malignant carcinoid tumours Eur. J. Cancer 28A 1647–1650 Occurrence Handle10.1016/0959-8049(92)90060-F Occurrence Handle1:STN:280:ByyD3c7lsVU%3D Occurrence Handle1382492

    Article  CAS  PubMed  Google Scholar 

  14. L Kolby G Persson S Franzen et al. (2003) ArticleTitleRandomized clinical trial of the effect of interferon alpha on survival in patients with disseminated midgut carcinoid tumours Br. J. Surg. 90 687–693 Occurrence Handle10.1002/bjs.4149 Occurrence Handle12808615

    Article  PubMed  Google Scholar 

  15. Frilling A, Rogiers X, Malago M, et al. Liver transplantation in patients with liver metastases of neuroendocrine tumors. Transplant Proc. 1998;30:3298–3300

    Google Scholar 

  16. LE Hanssen E Schrumpf MB Jacobsen et al. (1991) ArticleTitleExtended experience with recombinant alpha-2b interferon with or without hepatic artery embolization in the treatment of midgut carcinoid tumours: a preliminary report Acta Oncol. 30 523–527 Occurrence Handle1:STN:280:By6A3cjnvVc%3D Occurrence Handle1854510

    CAS  PubMed  Google Scholar 

  17. C Margarit R Charco E Hidalgo et al. (2002) ArticleTitleLiver transplantation for malignant diseases: selection and pattern of recurrence World J. Surg. 26 257–263 Occurrence Handle10.1007/s00268-001-0214-1 Occurrence Handle11865357

    Article  PubMed  Google Scholar 

  18. CA Hoefnagel FC Hartog Jager AH Gennip ParticleVan et al. (1986) ArticleTitleDiagnosis and treatment of a carcinoid tumor using iodine-131 meta-iodobenzylguanidine Clin. Nucl. Med. 11 150–152 Occurrence Handle1:STN:280:BimC283lvFY%3D Occurrence Handle3956021

    CAS  PubMed  Google Scholar 

  19. CA Hoefnagel (1994) ArticleTitleMetaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours Eur. J. Nucl. Med. 21 561–581 Occurrence Handle1:CAS:528:DyaK2cXmsV2msLY%3D Occurrence Handle7915987

    CAS  PubMed  Google Scholar 

  20. CA Hoefnagel BG Taal RA Valdes Olmos (1991) ArticleTitleRole of [131I]metaiodobenzylguanidine therapy in carcinoids J. Nucl. Biol. Med. 35 346–348 Occurrence Handle1:STN:280:By2A1crlsVM%3D Occurrence Handle1726678

    CAS  PubMed  Google Scholar 

  21. J Bomanji KE Britton E Ur et al. (1993) ArticleTitleTreatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I-metaiodobenzylguanidine Nucl. Med. Commun. 14 856–861 Occurrence Handle1:STN:280:ByuD2M%2FpsVA%3D Occurrence Handle8233228

    CAS  PubMed  Google Scholar 

  22. JJ Mukherjee GA Kaltsas N Islam et al. (2001) ArticleTitleTreatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine Clin. Endocrinol. (Oxf.) 55 47–60 Occurrence Handle10.1046/j.1365-2265.2001.01309.x Occurrence Handle1:CAS:528:DC%2BD3MXmtVKgtbw%3D

    Article  CAS  Google Scholar 

  23. BG Taal H Zuetenhorst RA Valdes Olmos et al. (2002) ArticleTitle[131I]mIBG radionuclide therapy in carcinoid syndrome Eur. J. Surg. Oncol. 28 243 Occurrence Handle10.1053/ejso.2001.1225 Occurrence Handle11944956

    Article  PubMed  Google Scholar 

  24. H Zuetenhorst BG Taal H Boot et al. (1999) ArticleTitleLong-term palliation in metastatic carcinoid tumours with various applications of meta-iodobenzylguanidine (mIBG): pharmacological mIBG, 131I-labelled mIBG and the combination Eur. J. Gastroenterol. Hepatol. 11 1157–1164 Occurrence Handle1:CAS:528:DC%2BD3cXltV2kt7w%3D Occurrence Handle10524647

    CAS  PubMed  Google Scholar 

  25. AA Pathirana S Vinjamuri C Byrne et al. (2001) ArticleTitle(131)I-mIBG radionuclide therapy is safe and cost-effective in the control of symptoms of the carcinoid syndrome Eur. J. Surg. Oncol. 27 404–408 Occurrence Handle10.1053/ejso.2001.1132 Occurrence Handle1:STN:280:DC%2BD3MzlslGrtw%3D%3D Occurrence Handle11417988

    Article  CAS  PubMed  Google Scholar 

  26. BG Taal CA Hoefnagel RA Valdes Olmos et al. (1996) ArticleTitlePalliative effect of metaiodobenzylguanidine in metastatic carcinoid tumors J. Clin. Oncol. 14 1829–1838 Occurrence Handle1:CAS:528:DyaK28Xkt1WksLo%3D Occurrence Handle8656251

    CAS  PubMed  Google Scholar 

  27. IE Moyssakis LS Rallidis GF Guida et al. (1997) ArticleTitleIncidence and evolution of carcinoid syndrome in the heart J. Heart Valve Dis. 6 625–630 Occurrence Handle1:STN:280:DyaK1c%2FovVGksw%3D%3D Occurrence Handle9427132

    CAS  PubMed  Google Scholar 

  28. PA Robiolio VH Rigolin JS Wilson et al. (1995) ArticleTitleCarcinoid heart disease: correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography Circulation 92 790–795 Occurrence Handle1:STN:280:ByqA28fotFU%3D Occurrence Handle7641358

    CAS  PubMed  Google Scholar 

  29. KC Loh PA Fitzgerald KK Matthay et al. (1997) ArticleTitleThe treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (13I-mIBG): a comprehensive review of 116 reported patients J. Endocrinol. Invest. 20 648–658 Occurrence Handle1:CAS:528:DyaK1cXhtFSrsLg%3D Occurrence Handle9492103

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Sydney Endocrine Surgical Unit, Royal North Shore Hospital, St. Leonards, New South Wales, Australia

    Mark S. Sywak M.B.B.S.

  2. Endocrine Tumour Oncology Group, Tom Baker Cancer Centre and University of Calgary, Calgary, Alberta, Canada

    Janice L. Pasieka M.D., Greg Kline M.D. & Otto Rorstad M.D., Ph.D.

  3. Department of Nuclear Medicine, Cross Cancer Institute and University of Alberta, Edmonton, Alberta, Canada

    Alexander McEwan M.D.

Authors
  1. Mark S. Sywak M.B.B.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Janice L. Pasieka M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alexander McEwan M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Greg Kline M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Otto Rorstad M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Janice L. Pasieka M.D..

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sywak, M., Pasieka, J., McEwan, A. et al. 131I-Meta-iodobenzylguanidine in the Management of Metastatic Midgut Carcinoid Tumors. World J. Surg. 28, 1157–1162 (2004). https://doi.org/10.1007/s00268-004-7603-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-004-7603-1

Keywords

Search

Navigation